Clinical trials
Completed Acquired Immunodeficiency Syndrome trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 3 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 7 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 89 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ViiV Healthcare | 18 |
| Gilead Sciences | 5 |
| Hoffmann-La Roche | 5 |
| Canadian Immunodeficiency Research Collaborative | 4 |
| Glaxo Wellcome | 4 |
| Pfizer | 4 |
| Unity Health Toronto | 4 |
| Tibotec Pharmaceuticals, Ireland | 3 |
| University of Toronto | 3 |
| GlaxoSmithKline | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 89 |
| HIV Infections | 48 |
| Infections | 13 |
| AIDS-Related Opportunistic Infections | 8 |
| Cytomegalovirus Infections | 5 |
| Hepatitis C | 5 |
| AIDS-Related Complex | 4 |
| Cytomegalovirus Retinitis | 4 |
| Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 4 |
| Retinitis | 4 |
Trials
Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.